After years of research and clinical testing, we have developed non-invasive, accurate blood tests for early detection of cancer. By making cancer prevention routine, we enable everyone to take control of their own health. The more people take our breakthrough blood tests, the more lives we can save. Life over cancer.
Select Publications and Abstracts
Analytical validation of a novel circulating tumor DNA detection platform for targeted and immunotherapy selection; AACR Annual Meeting, 2018
Pratyush Gupta, Julian Lucas, Alex Atkins, Wen-Sy Tsai, Twinkal Marfatia, Shih-En Chang, Oscar Segurado, Rui Mei
Comparison of rare pathogenic germline variants associated with cancer predisposition syndrome in Taiwan and USA populations; AACR Annual Meeting, 2018
Zulfiqar Gulzar, Julian Lucas, Alex Atkins, Stephen Su, Oscar Segurado, Rui Mei
CTC and ctDNA profiling to detect 6 NCCN-guideline recommended classes of alterations for immunotherapy and targeted therapy selection using sample from a single blood draw; AACR Annual Meeting, 2018
Huangpin B. Hsieh, Jen-Chia Wu, Feng-Ming Lin, Julian Lucas, Alex Atkins, Pratyush Gupta, Hung-Jen Shao, Yen-Lin Chen, Wen-Jie Huang, Chia-Hsun Hsieh, Ruey Kuen Hsieh, Kuo-Wei Chen, Ming-Hong Yen, Mana Javey, Shih-En Chang, Twinkal Marfatia, Drew Watson, Mahul Amin, Ashish Nimgaonkar, Oscar Segurado, Rui Mei
CellMax Life is a leading cancer diagnostics company whose mission is to transform how cancer is diagnosed and managed with globally affordable non-invasive tests for early cancer detection and management. CellMax’s unique expertise in both Circulating Tumor Cell and Next Generation Sequencing of DNA and circulating tumor DNA (ctDNA) has enabled multiple highly effective precision medicine solutions for healthy people as well as patients diagnosed with cancer.
1271 Oakmead Parkway
Sunnyvale, CA 94085
Phone: +1 650-564-3905
18F-1 Park Street
Nangkang, Taipei City
(+886) 0800-555-885 (Taiwan)